OrphoMed, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2015-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.orphomed.com
A Comparison of the Effects of ORP-101 Versus Placebo in Adult Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Phase 2
Completed
- Conditions
- Irritable Bowel Syndrome With Diarrhea
- Interventions
- Drug: Placebo
- First Posted Date
- 2019-10-17
- Last Posted Date
- 2022-03-04
- Lead Sponsor
- OrphoMed, Inc.
- Target Recruit Count
- 321
- Registration Number
- NCT04129619
- Locations
- 🇺🇸
Sierra Clinical Research (Site 179), Las Vegas, Nevada, United States
🇺🇸Hometown Urgent Care and Research (Site 149), Columbus, Ohio, United States
🇺🇸Tristar Clinical Investigations, P.C. (Site 168), Philadelphia, Pennsylvania, United States
© Copyright 2025. All Rights Reserved by MedPath